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and reproduction in any medium, provided the original wWnt/b-catenin signalling controls adult heart remodelling in part via regulation
of cardiac progenitor cell (CPC) differentiation. An enhanced understanding of
mechanisms controlling CPC biology might facilitate the development of new
therapeutic strategies in heart failure. We identified and characterized a novel
cardiac interaction between Krueppel-like factor 15 and components of the
Wnt/b-catenin pathway leading to inhibition of transcription. In vitro mutation,
reporter assays and co-localization analyses revealed that KLF15 requires both
the C-terminus, necessary for nuclear localization, and a minimal N-terminal
regulatory region to inhibit transcription. In line with this, functional Klf15 knock-
out mice exhibited cardiac b-catenin transcriptional activation along with
functional cardiac deterioration in normal homeostasis and upon hypertrophy.
We further provide in vivo and in vitro evidences for preferential endothelial
lineage differentiation of CPCs upon KLF15 deletion. Via inhibition of b-catenin
transcription, KLF15 controls CPC homeostasis in the adult heart similar to
embryonic cardiogenesis. This knowledge may provide a tool for reactivation
of this apparently dormant CPC population in the adult heart and thus be an
attractive approach to enhance endogenous cardiac repair.INTRODUCTION
A couple of studies have shown the capacity of adult
mammalian heart cells to proliferate especially after injury
(Beltrami et al, 2001; Bergmann et al, 2009; Hsieh et al, 2007;
Kajstura et al, 2004). Specific groups of putative cardiac
progenitor cell (CPC) populations have been identified and
characterized including c-kit (Beltrami et al, 2003), Islet-1
(Laugwitz et al, 2005;Moretti et al, 2006;Wang et al, 2006), Sca1sity Medical Center
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ork is properly cited and is(Oh et al, 2003), side population cells (Pfister et al, 2005, 2010)
and cardiac neural crest-derived cells (Tomita et al, 2005).
However, some studies showed insignificant rate of cardiac
proliferation (Rubart & Field, 2006). Nonetheless, the extent to
which these cells contribute to tissue homeostasis and/or repair
as well as the signalling pathways controlling their proliferation
and differentiation remains unclear. This scenario leads to a lack
of robust endogenous cardiac regeneration to replace the
infarcted myocardium. Therefore, understanding the mecha-
nisms that control progenitor cells during normal cardiac
homeostasis and repair is the basis for developing new
therapeutic strategies to activate these cells for effective
regeneration.
The notion that genes involved in early cardiogenesis may be
re-employed to protect or regenerate heart muscle hasmotivated
efforts to understand early developmental pathways (Epstein &
Parmacek, 2005; Oka et al, 2007). One important factor
regulating progenitor cell biology during early cardiogenesis
is the canonical Wnt/b-catenin pathway. Active Wnt/b-catenins is an open access article under
.0), which permits use, distribution
not used for commercial purposes. EMBO Mol Med (2012) 4, 992–1007
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then associates with lymphoid enhancer factor and T-cell factor,
such as transcription factor 7-like 2 (TCF7L2 or TCF4) to form a
transcription complex that activates Wnt target genes. This
cascade is subject to multiple levels of negative control where,
among others, the Nemo-like kinase (NLK) play an important
role by interacting with and phosphorylating TCF to repress
b-catenin/TCF-mediated transcription (Ishitani et al, 2003).
Wnt/b-catenin signalling controls maintenance, proliferation
and differentiation of embryonic cardiovascular progenitors in a
multi-phasic fashion. Initially, Wnt/b-catenin pathway has a
positive effect on embryonic mesodermal cell activation and
proliferation. Subsequent inactivation is required for proper
differentiation into functional cardiomyocytes while default
activation leads the cells to a haemangioblast lineage (Gessert &
Kuhl, 2010; Naito et al, 2006; Ueno, 2007). Interestingly, gene
expression profiling analysis indicated a participation of
Wnt signalling also in pathological myocardial remodelling
(LaFramboise et al, 2005; Toischer et al, 2010). We previously
demonstrated that cardiac b-catenin downregulation is required
for adaptive hypertrophy and enhances endogenous CPC
cardiomyogenic differentiation after infarction (Baurand et al,
2007; Zelarayan et al, 2008). Collectively, the available data
argues strongly for a pivotal role of Wnt/b-catenin signalling in
embryogenic and postnatal heart.
Krueppel-like factors (KLF) are a large family of zinc finger-
containing transcription factors involved in diverse arrays of
cellular processes including regulation of cell differentiation,
cardiac remodelling, haematopoiesis, angiogenesis and stem
cell-fate determination by interacting with co-activators and co-
repressors (Kaczynski et al, 2003). Recent studies revealed the
important role of KLF15 as a central regulator of stress response
and repressor of pathological cardiac hypertrophy and fibrosis
by controlling factors such as GATA binding protein 4 (GATA4),
myocyte enhancer factor-2 (MEF2), myocardin (Fisch et al, 2007;
Leenders et al, 2010) and the transforming growth factor b
(TGFb) (Wang et al, 2008), respectively. However, the role of
KLF15 in stem cell biology of the adult heart remains unexplored.
Here, we report a novel interaction between KLF15 and
components of the Wnt pathway resulting in an inhibition of
b-catenin/TCF-transcriptional activity in cardiac cells. The
biological role of this interaction was investigated in vitro
and in vivo in the postnatal hearts of mice with a global KLF15
functional deletion. These mice exhibited a cardiac b-catenin/
TCF-transcriptional de-repression and cardiac dysfunction.
Deletion of KLF15 results in a constitutive b-catenin transcrip-
tional activation that directs the CPCs to an endothelial
phenotype. Collectively, our data underscore the relevance of
KLF15 and the Wnt/b-catenin pathway for cardiac cellular
homeostasis.RESULTS
KLF15 interacts with b-catenin, NLK and TCF4 in cardiac cells
Based on previous observations concerning b-catenin and its
beneficial role in cardiac remodelling, we sought to identify newEMBO Mol Med (2012) 4, 992–1007b-catenin interaction partners by means of a yeast-two-hybrid
screen. We identified and characterized a specific interaction
between b-catenin and a member of the Krueppel-like
transcription factor family, KLF15. To validate this interaction,
we initially co-transfected the human embryonic cells HEK293
with cmyc-b-catenin and Flag-KLF15-full-length plasmids.
b-catenin was immunoprecipitated with an anti-c-myc antibody
and KLF15 detection was performed with an anti-Flag antibody.
A clear band in the KLF15 expected size was detected, thus,
confirming the interaction between KLF15 and b-catenin
(Fig 1A, lane 3). Moreover, we verified the endogenous
interaction of these proteins using antibodies against b-catenin
and KLF15 in adult mouse cardiac tissue (Fig 1A, lane 8). To
identify the binding domain, HEK293 were co-transfected with
cmyc-b-catenin and N-terminal mutants lacking the first 45, 152
and 260 amino acids (DN45, DN152, DN260) or a C-terminal
truncated KLF15 (-DC) plasmid. Co-immunoprecipitation
revealed that deletion of the 260 N-terminal amino acids
in the KLF15 sequence abrogated the b-catenin binding
(Fig 1A, lane 4–6), while lack of the KLF15 C-terminus did
not play a role (Fig 1A, lane 7).
Next, we investigated the potential interaction of additional
factors among the Wnt/b-catenin components. By co-immuno-
precipitation we found that the NLK, a known inhibitor of the
b-catenin-LEF/TCF complex (Ishitani et al, 1999; Yamada et al,
2006), interacted with KLF15. HEK293 cell lysates transfected
with Flag-KLF15-full-length and haemagglutinin (HA)-NLK-full-
length were immunoprecipitated with an anti-HA antibody
and KLF15 detection was performed with an anti-Flag antibody.
The endogenous interaction was further confirmed in
adult mouse cardiac cells (Fig 1B, line 3 and 8). Flag-KLF15-
(DN45, DN152, DN260 and -DC) and HA-NLK-full-length were
transfected in HEK293 cells to identify binding domains.
Co-immunoprecipitation revealed that KLF15-DN45 and -DC
but not the KLF15-DN152 and DN260 interacted with NLK
(Fig 1B, line 4–7).
Since NLK interacts with and phosphorylates TCF to repress
b-catenin/TCF-mediated transcription (Ishitani et al, 2003), we
tested KLF15 and TCF4 interaction. HEK293 cells were co-
transfected with a HA-TCF4 and Flag-KLF15-full-length. TCF4
was immunoprecipitated with an anti-HA antibody and KLF15
was detected using an anti-Flag antibody. This analysis showed
interaction of KLF15 with TCF4, which was further confirmed
endogenously in adult mouse cardiac cells (Fig 1C, line 3 and 8).
TCF4 interaction with KLF15-DN45, -DN152, -DN260, -DC
mutants was tested in HEK293 cells. Co-immunoprecipitation
showed interaction of TCF4 with all the N-terminal KLF15-
mutants but not with the KLF15-DC (Fig 1C, line 4–7). As
positive controls b-catenin/TCF4 and b-catenin/NLK known
interactions were confirmed in HEK293 cells (Supporting
Information Fig S1A). The corresponding controls for the
KLF15 antibody used for endogenous detection are provided in
Supporting Information Fig S1B.
Altogether these data show the association of KLF15 to the
b-catenin/TCF complex, where the first 45 amino acids of KLF15
are essential for binding b-catenin, amino acids 45–152 for
binding NLK and the C-terminal region for TCF4. 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 993
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Figure 1. KLF15 interacts with b-catenin, NLK and TCF4. The transfected constructs in A, B and C were detected in the protein lysates. IgG isotype (IP-CT)
(lane 1) and empty vector (EV) (lane 2) were used as controls; GAPDH served as loading control. (A, B and C) Endogenous validation of the identified interactions
between KLF15 and b-catenin, NLK as well as TCF4 in adult cardiac tissue are depicted (lane 8). Lane 9 shows the IgG isotype control for IP. Endogenous detection
of KLF15, b-catenin, NLK as well as TCF4 in the different lysates is shown. () IgG heavy chain (50 kDa).
A. Co-immunoprecipitation (IP) analysis showing interaction of KLF15 and b-catenin in HEK293 cells overexpressing cmyc-b-catenin and Flag-KLF15-full-length
(lane 3). Co-transfection of truncated (DN45, DN152, DN260)-KLF15 (lane 4–6) or a DC-KLF15 (lane 7) and cmyc-b-catenin plasmids in HEK293 cells showing
the requirement of the first 45 amino acids of KLF15 for binding b-catenin.
B. Interaction of NLK with KLF15-full-length, -DN45 (lane 3 and 4) and -DC (lane 7) were shown by co-IP assays in HEK293.
C. TCF4 interacted with KLF15-full-length and all N-terminal mutants (lane 3–6), but not with the -DC construct (lane 7) in HEK293.
994KLF15 requires the C-terminal domain for nuclear
localization
To localize the KLF15/b-catenin and KLF15/NLK interactions,
we detected the endogenous expression of these proteins in
neonatal rat cardiomyocytes (NRC) by immunofluorescence.
We observed a co-localization of b-catenin and KLF15 as well as
NLK and KLF15 in the nucleus (Fig 2A) suggesting the role of
KLF15 as transcriptional regulator. NRC were co-transfected
with both b-catenin and either Flag-KLF15-full-length or the
indicated mutants. Immunofluorescence analysis showed co-
localization of the KLF15-full-length as well as the N-terminal
mutants of KLF15 with b-catenin in the nucleus, while the
KLF15 construct lacking the C-terminal domain was exclusively
found in the cytoplasm (Fig 2A). Immunoblot of enriched-cell
fractions confirmed the nuclear localization of KLF15-DN
mutants and the cytosolic localization of KLF15-DC (Fig 2B)
suggesting that the C-terminal domain responsible for TCF
binding is important for nuclear translocation. 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.The N-terminal KLF15 domain mediates inhibition of
b-catenin/TCF4 transcriptional activity
We further investigated the role of these interactions in b-
catenin signalling in NRC and HEK293 employing the pTOPflash
reporter plasmid, which is activated when b-catenin binds to
LEF/TCF elements driving firefly luciferase expression. KLF15
expression suppressed endogenous b-catenin-induced lucifer-
ase activity in NRC (p< 0.001, Fig 3A) and in HEK293 cells
(Supporting Information Fig S1B). Furthermore, co-transfection
of a stabilized form of b-catenin (b-cat-DN)was used to increase
reporter activity. KLF15 expression was able to suppress the b-
cat-DN-induced luciferase in NRC (p< 0.001, Fig 3A) and in
HEK293 cells (Supporting Information Fig S1B) in a concentra-
tion-dependent manner. Next, we tested the effect of KLF15 on
TCF-mediated signalling in SW480 cells, a tumour cell line that
has constitutive active transcriptional b-catenin/TCF activity.
Likewise, KLF15 repressed the endogenous and TCF4-induced
luciferase expression in SW480 cells (p< 0.001, Fig 3B).EMBO Mol Med (2012) 4, 992–1007
www.embomolmed.org Research Article
Claudia Noack et al.
A
B
β-catenin NLK/β-catenin/DAPINLK
NLK/KLF15/DAPIKLF15NLK
NLK NLK/TCF4/DAPITCF4
KLF15-∆N45
KLF15-∆N152
KLF15-∆N260
KLF15-∆C
KLF15/β-cat/DAPIKLF15 β-catenin
α-Tubulin
Lamin A/C
Flag-KLF15
EV KL
F1
5
-∆
N4
5
-∆
C
-∆
N1
52
-∆
N2
60
NuclearCytosolic
55
34
17
kDa EV KL
F1
5
-∆
N4
5
-∆
C
-∆
N1
52
-∆
N2
60
72
52
72
55
Figure 2. KLF15 requires the C-terminus for nuclear localization.
A. Co-localization assays in NRC show that KLF15-full-length as well as KLF15-N-terminal mutants (DN45,DN152 andDN260) co-localized with b-catenin in the
nucleus, while KLF15-DC was localized in the cytosol. KLF15, b-catenin and TCF4 were detected together with NLK in the nuclear compartment.
B. Immunoblots of enriched cell fractions confirming the subcellular localization of KLF15-DN forms in the nucleus and the DC-construct in the cytosol. Tubulin
and Lamin A/C served as loading controls for cytosolic and nuclear lysates, respectively.Analysis of the different KLF15 mutants on b-catenin/TCF
transcription showed that only KLF15-DN45 was able to repress
b-cat/TCF-induced luciferase in contrast to mutants lacking
longer N-terminal regions as well as the C-terminus in NRC,
SW480 and HEK293 (Fig 3A and B and Supporting Information
Fig S1C). Thus, the required domain for b-catenin/TCF-
transcriptional repression seems to be localized in the
N-terminal fragment excluding the first 45 amino acids of the
KLF15 protein. Our observations reveal that KLF15 requires
both, a minimal N-terminal domain for binding b-catenin and
NLK as well as a C-terminal domain for TCF binding and
nuclear translocation to achieve b-catenin/TCF transcriptional
repression (summarized in Fig 3E).
KLF15 inhibition on b-catenin-LEF/TCF-transcription did not
affect b-catenin localization or protein levels (Fig 3C), therefore,
we hypothesized that NLK and KLF15 affects TCF stability. We
tested ubiquitination of TCF4 upon KLF15 overexpression in
HEK293 cells. NLK co-expression was used as a positive control
since NLK was shown to target TCF4 for ubiquitination (Ishitani
et al, 1999). HA-TCF4 was immunoprecipitated from cytosolic
lysates and detected with an anti-ubiquitin antibody. We
observed comparable increased TCF4 ubiquitination in both
KLF15/TCF4 and NLK/TCF4 expressing cells. In contrast,
ubiquitination in cells expressing TCF4 alone was comparable
with cells transfected with the empty vector (EV; Fig 3D).
These findings show that KLF15 promotes TCF4 proteasomal
degradation.EMBO Mol Med (2012) 4, 992–1007KLF15 regulates Wnt/b-catenin activation in cardiac tissue
in vivo
Since we found that KLF15 regulates b-catenin-dependent
transcription in vitro, we tested the hypothesis that this
regulation takes place in the adult heart. Therefore, we analyzed
a Klf15 functional knock-out mouse model (Klf15 KO), carrying
an out-of-frame insertion of a partial lacZ cassette replacing
exon 2 of the KLF15 coding region (Supporting Information
Fig S2A). Klf15 KO mice were viable and fertile and showed
no apparent defects at baseline. Quantitative real time (qRT)-
PCR analysis of cardiac tissue demonstrated no Klf15 mRNA
expression in Klf15 KO mice (Supporting Information Fig S2B).
Histological analysis of liver, kidney, and lung up to 6months of
age showed no apparent morphological defects (Supporting
Information Fig S2C). KLF15 exerted inhibition of b-catenin
transcription, thus an opposite effect was expected upon
KLF15 deletion. Indeed, analysis of cardiac tissue of 16-week-
old mice revealed that b-catenin expression remained
unchanged, but its target genes Tcf4 and cMycwere significantly
increased at the mRNA (p< 0.05; Fig 4A) and protein level
(Fig 4B) in Klf15 KO versus wild-type (WT) mice. Endogenous
ubiquitination of TCF4 was significantly decreased in Klf15 KO
(Supporting information Fig S3) complementing the in vitro
finding showing increased TCF4 ubiquitination upon KLF15
overexpression. These observations show an in vivo cardiac
de-repression of b-catenin/TCF-transcriptional activity in
absence of KLF15. 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 995
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Figure 3. KLF15 inhibits b-catenin/TCF-transcriptional activity via its N-terminal domain and promotes degradation of TCF4.
A. The activation of the LEF/TCF-dependent luciferase reporter (pTOPflash) upon endogenous and stabilized b-catenin (b-cat-DN) was significantly inhibited by
KLF15 in a concentration-dependent manner (250 ng–250 pg) in NRC. Among the KLF15 N-terminal mutants (DN45, DN152 and DN260) only KLF15-DN45
suppressed the LEF/TCF reporter activation. KLF15 mutant lacking the C-terminus (-DC) was not able to repress LEF/TCF reporter activation.
B. Similarly, TCF4-induced reporter activation was significantly inhibited by KLF15 full-length as well as by KLF15-DN45 in SW480 cells, containing constitutive
active transcriptional b-catenin/TCF activity. KLF15 constructs lacking longer N-terminal regions and KLF15-DC did not show repression. pFOPflash: negative
control; Renilla luciferase expression was used for normalization. Data are mean SEM; ANOVA, Bonferroni’s multiple comparison test, p< 0.001.
C. Immunoblot of cytosolic and nuclear fraction of b-catenin in KLF15 transfected HEK293 showing no change in b-catenin protein levels.
D. Co-transfection of KLF15 with TCF4 resulted in enhanced TCF4 ubiquitination, which was comparable to NLK/TCF4 co-expression.
E. Summary of the identified protein interaction, subcellular localization and transcriptional repression of the different KLF15 constructs.
996Analysis of cardiac function assessed by ejection fraction (EF)
and fractional shortening (FS) showed significant reduction in
left ventricular (LV) function at 16 weeks of age in Klf15 KO
compared to WT at baseline (p< 0.05; Fig 4C). Neither wall
thickness nor end-diastolic dimension of the LV (LVEDd) or
cardiac mass showed significant differences between Klf15
KO and WT mice (Supporting Information Table S1A). Since
b-catenin/TCF-transcriptional activity was increased in the
adult heart of Klf15 KO mice, we were interested in the cardiac 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.phenotype of mice exhibiting a direct cardiac b-catenin
upregulation. We previously described a mouse model with
cardiac inducible b-catenin stabilization (b-catDex3) showing
worse cardiac function compared with controls after Angio-
tensinII (AngII)-induced hypertrophy (Baurand et al, 2007).
Now, we analyzed cardiac function of b-catDex3 mice 16 weeks
following induction of b-catenin stabilization. Similar to the
functional phenotype observed in Klf15 KOmice, b-catDex3 mice
showed a significant decrease in EF and FS (Fig 4D). NoEMBO Mol Med (2012) 4, 992–1007
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Figure 4. KLF15 regulates Wnt/b-catenin activity in cardiac tissue in vivo. Data represent mean SEM; two-tailed Student’s t-test, p< 0.05.
A. Unchanged mRNA expression of b-catenin but significantly increased expression of its target genes cMyc and Tcf4 in Klf15 KO versus WT adult heart.
B. Same observation as shown in A at the protein level.
C. Fractional shortening (FS) and ejection fraction (EF) showing initial mild cardiac functional deterioration, which was aggravated with age in Klf15 KO versus
WT mice (n¼10).
D. 16 weeks of b-catenin stabilization resulted in a significant decrease in FS and EF in mice with cardiac specific b-catenin stabilization (b-catDex3).differences were observed inwall thickness and/or cardiacmass
between b-catDex3 and control mice (Supporting Information
Table S1B). These observations suggest that KLF15-dependent
regulation of b-catenin-dependent transcription is important to
maintain normal cardiac homeostasis.
To discern the cause of the observed phenotype we
investigated the expression of foetal genes A-type natriuretic
peptide (ANP), B-type natriuretic peptide (BNP), GATA4 and
connective tissue growth factor (CTGF) by qRT-PCR since it was
shown that KLF15 regulates hypertrophic signalling and fibrosis
(Fisch et al, 2007; Wang et al, 2008). No significant differences
were observed between KO andWTmice with respect to cardiac
hypertrophy, fibrosis as well as apoptosis (Supporting Informa-
tion Fig S4A-D). Our data strongly suggest that regulation of
hypertrophy and fibrosis via KLF15 occurs exclusively upon
cardiac stress and are not the explanation for baseline cardiac
deterioration.
KLF15 controls cardiac progenitor cell fate in the adult
murine heart
Since we previously demonstrated that downregulation of
b-catenin enhanced differentiation of Sca1-derived cardiomyo-
genic progenitor cells post-infarction (Zelarayan et al, 2008), we
tested the hypothesis that KLF15-dependent regulation of
b-catenin transcription affects CPC homeostasis. Expression
of KLF15 was confirmed in the total CPCs as well as in the
Sca1pos sub-population as demonstrated by qRT-PCR andEMBO Mol Med (2012) 4, 992–1007Western blot (Fig 5A and B). Whole heart lysate was used as
control. The non-cardiomyocyte cell fraction containing CPCs
isolated from 16-week-old Klf15 KO and WT were analyzed by
flow cytometry. The cell-cycle analysis showed a decreased cell
number in G0/G1 resting phase and an increased cell number of
cells in G2/M phase indicative of an increased number of
dividing progenitors in Klf15 KO mice (p< 0.05; Fig 5C).
Furthermore, we investigated specific CPCs sub-populations
previously described in the adult heart. The total number
of Sca1pos and c-kitpos sub-populations were significantly
increased in KO mice (p< 0.001 and <0.05; Fig 5D), although
it is important to mention that the c-kit population was very low
in both WT and Klf15 KO mice. Next, we analyzed these CPC
sub-populations in combination with endothelial and cardio-
myogenic markers to identify progenitor cells in transition to
different lineages (see Supporting Information Fig S5 for
controls). Cells co-expressing Sca1 or c-kit and the endothelial
cell marker CD31 were significantly increased in Klf15 KO mice
(p< 0.001 and <0.05; Fig 5D). In contrast, we observed a
significant reduction of Sca1pos/aMHCpos as well as the
Tbx5pos/cTnTneg cardiomyogenic populations in Klf15 KO in
comparison toWTmice (p< 0.001 and<0.05, respectively). No
significant changes were detected in the double populations
labelled by c-kit and the cardiomyogenic markers aMHC and
Hand1 (Fig 5D).
While the total (Ki67pos) and endothelial proliferating cell
fraction (Ki67pos/CD31pos) was significantly increased in Klf15 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 997
Research Article www.embomolmed.org
KLF15 and cardiac progenitor cell fate regulation
C
WT KO
70
72
74
76
78
80
82
*
G
0/
G
1 
ph
as
e 
(%
)
WT KO
6
7
8
9
10
11
12
13
*
G
2/
M
 p
ha
se
 (%
) KO WTG0/G1
G2/M
C
ou
nt
s
FL2-A
B
D
CD133
WT KO
0.005
0.010
0.015
0.020
0.025
**
A
0.5
1.0
1.5 *
to
ta
l c
-k
itp
os
 (%
)
0.1
0.2
0.3 *
c-
ki
tp
os
/C
D
31
po
s  
(%
)
0.05
0.10
0.15
0.20
0.25
c-
ki
tp
os
/α
M
H
C
po
s  
(%
)
0.05
0.10
0.15
0.20
0.25
c-
ki
tp
os
/H
an
d1
po
s  
(%
)
2
4
6
8
10
12 ***
Sc
a1
po
s /
C
D
31
po
s  
(%
)
5
10
15
20
25 ***
to
ta
l S
ca
1p
os
 (%
)
0.5
1.0
1.5
2.0 ***
Sc
a1
po
s /
α
M
H
C
po
s  
(%
)
1
2
3
4
5
6 *
Tb
x5
po
s /
cT
nT
ne
g  
(%
)
endothelial cardiomyogenic
WT KO
0.5
1.0
1.5
2.0
2.5 *
K
i6
7p
os
/C
D
31
po
s  
(%
)
WT KO
0.5
1.0
1.5
2.0
K
i6
7p
os
/α
M
H
C
po
s  
(%
)
WT KO
1
2
3
4
5
6
K
i6
7p
os
/H
an
d1
po
s  
(%
)
WT KO
2
4
6
8
10
12
14 *
to
ta
l K
i6
7p
os
 (%
)
E
WT KO WT KO
0
1
2
3
4 *
**
Sham TAC
*
Tb
x5
po
s /
cT
nT
ne
g  
(%
)F
WT KO WT KO
TACSham
G
vWF
re
l. 
m
R
N
A
 e
xp
re
ss
io
n
0.1
0.2
0.3 **
WT KO
CD105
WT KO
0.05
0.10
0.15
0.20 ***
Tcf4
0.2
0.4
0.6
* **
re
l. 
m
R
N
A
 e
xp
re
ss
io
n
WTKO WTKO
TACSham
0.1
0.2
0.3
***
**
vWF CD105
WTKO WTKO
TACSham
0.05
0.10
0.15
0.20
***
*
total
heart
total
CPC Sca1pos-RT
Klf15
Gapdh
GAPDH
KLF15
kDa Sca1pos
total
heart
total
CPC
34
40
50
Figure 5.
998  2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. EMBO Mol Med (2012) 4, 992–1007
www.embomolmed.org Research Article
Claudia Noack et al.
3KO mice (p< 0.05), the cardiomyogenic proliferative cells,
Ki67pos/aMHCpos, and Ki67pos/Hand1pos, were unchanged
(Fig 5D). Moreover, we detected increased mRNA expression
of endothelial markers von Willebrand Factor (vWF)
(p< 0.001) and Endoglin/CD105 (p< 0.01). Expression of
CD133, which is known to be lost upon endothelial cell
differentiation, was significantly reduced (p< 0.01) in cardiac
tissue of Klf15 KO versusWTmice (Fig 5E). Together these data
show an increased progenitor cell fraction, which exhibits an
endothelial phenotype in the Klf15 KO mice.
Next, we were interested in the effect of KLF15 depletion in
CPCs upon cardiac remodelling. Therefore, we applied a mild
stimulus to induce hypertrophy by AngII and a more stringent
stimulus by transverse aortic constriction (TAC) in 12-week-old
Klf15 KO andWTmice. In line with previous functional studies,
2 weeks following AngII treatment, Klf15 KO showed accen-
tuated cavity dilation as shown by LV diameter measurement
(p< 0.01; Supporting Information Fig S6A and Table S2A).
FACS analysis revealed that the Sca1pos/aMHCpos as well as the
Tbx5pos/cTnTneg populations were significantly decreased in
Klf15 KO versus WT mice (p< 0.01) upon AngII infusion
(Supporting Information Fig S6B). Two weeks following TAC,
stronger dilation of the LV and accentuated cardiac dysfunction
along with increased mortality was observed in Klf15 KO in
comparison to WT mice (p< 0.01; Supporting Information Fig
S6C-D and Table S2B). Upregulation of TCF4 mRNA expression
(p< 0.01; Fig 5F), reduction of the cardiomyogenic Tbx5pos/
cTnTneg population (p< 0.05; Fig 5G) and significant upregula-
tion of vWF and CD105 expression (p< 0.001 and <0.05,
respectively; Fig 5F) were confirmed in Klf15 KO mice upon
TAC. Altogether these data indicate that loss of KLF15 induces
an activation of b-catenin-dependent transcription and this
reduces the cardiomyogenic progenitor cell pool both in the
normal and stressed adult heart.
Endothelial identity of Sca1pos CPCs in Klf15 KO mice
Since we found expression of KLF15 in Sca1pos cells, we used
this marker to assess gene regulation analysis in a purified
cardiac progenitor population. The cardiac Sca1pos cells were
purified from Klf15 KO and WT mice by magnetic cell sortingigure 5. KLF15 controls cardiac progenitor cell fate in the postnatal heart. Data represent mean SEM, (C) to (E) two-tailed Student’s t-test; (F) and (G)
NOVA; Bonferroni’s multiple comparison test, p<0.05, p<0.01, p<0.001.
. QRT-PCR analysis.
. Western blot analysis showed KLF15 expression in total CPCs and more specific in Sca1pos sub-population. Whole heart, containing all different cell
populations, was used as control for KLF15 expression, as expected the expression is most robust in this fraction. RT was used as control for the RT-PCR.
. Cell cycle analysis shows significantly reduced cell number in G0/G1 but upregulation in G2/M phase in isolated CPCs of Klf15 KO versus WT (n8).
. FACS analysis of isolated adult CPCs revealed regulation of Sca1pos and c-kitpos population upon KLF15 depletion. Significant increase of total Sca1pos and
c-kitpos cells was observed along with increased endothelial cell pool (Sca1pos/CD31pos, c-kitpos/CD31pos) in Klf15 KO versus WT mice at baseline (n 9).
In contrast, cells of the cardiomyogenic lineage (Sca1pos/aMHCpos, Tbx5pos/cTnTneg) were significantly reduced in Klf15 KO versus WT mice. The c-kit
cardiomyogenic lineage (c-kitpos/Hand1pos, c-kitpos/aMHCpos) were unchanged. Total and endothelial (Ki67pos/CD31pos) proliferating CPCs were increased
while proliferation of cardiomyogenic cells was unchanged (aMHCpos, Hand1pos, co-stained with Ki67pos) in Klf15 KO mice (p<0.05).
. QRT-PCR analysis of total cardiac tissue resulted in enhanced expression of endothelial markers vWF and CD105, and reduced CD133 expression in Klf15 KO
versus WT mice.
Two weeks after TAC upregulation of TCF4 and increased endothelial marker (vWF and CD105) expression in Klf15 KO versus WT was confirmed by qRT-PCR
analysis of cardiac tissue.
. Further decrease of the cardiomyogenic CPCs (Tbx5pos/cTnTneg) population as shown by FACS analysis in TAC-operated Klf15 KO in comparison to sham-KO
(n> 8).F
A
A
B
C
D
E
F.
GEMBO Mol Med (2012) 4, 992–1007(MACS). 96.4% purity of sorted Sca1pos cells was confirmed
by flow cytometry. Analysis of the Wnt/b-catenin pathway by
qRT-PCR showed upregulation of the b-catenin target genes
cMyc and TCF4 in the purified Sca1 cell population. The early
mesodermal haemangioblast marker Flk1 as well as the
endothelial markers vWF, CD105 were upregulated while the
cardiomyogenic markers aMHC and Hand1 were lower
expressed in Klf15 KO mice in comparison to WT Sca1pos cells
(Fig 6A). These data further support the role of KLF15 in CPC cell
fate determination in the adult heart.
KLF15 deletion directs CPCs to acquire an endothelial
phenotype via activation of b-catenin dependent transcription
Loss of KLF15 results in upregulation of b-catenin transcription
and promotes an endothelial phenotype of CPCs. In contrast, we
previously described that cardiac inducible deletion of b-catenin
(b-catDex2–6) enhanced cardiomyogenic CPC differentiation
(Zelarayan et al, 2008). Now, we reasoned that b-catenin
transcriptional inactivation would lead to the opposite regula-
tion of endothelial fate of CPCs in comparison to KLF15.
Therefore, we analyzed the CPC fraction in b-catDex2–6 by FACS
and found indeed a significant reduction of CD31pos as well as
Ki67pos/CD31pos CPCs in comparison to control mice (Fig 6B).
This observation was confirmed by a semi-quantitative
immunohistochemistry analysis, which shows enhanced
CD31 positive areas in Klf15 KO in comparison to control mice
and moreover, a significant reduction of in b-catDex2–6 (Fig 6C
and D).
To further elucidate themechanism of KLF15 to drive CPC cell
fate determination we established a co-culture systemwith adult
cardiac fibroblasts as feeder layer for the enriched adult CPCs.
The same cell number of cardiovascular progenitors from Klf15
WT and KO mice were plated and cultured on arrested adult
cardiac fibroblasts. Following 10 days co-culture an augmented
cell population was detected in the Klf15 KO cultured cells in
comparison toWT cells when analyzed by flow cytometry (Gate
G1; Fig 7A). Similar to our in vivo finding, we found a highly
proliferative Ki67pos cell fraction (p< 0.05) along with a
decrease in aMHCpos (p< 0.01) and Hand1pos expressing cells.
Interestingly, cells expressing Flk1 were augmented (p< 0.01; 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 999
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Figure 6. Klf15 deletion and b-catenin downregulation results in opposite regulation of endothelial CPC fate. Data represent mean SEM; (B): two-tailed
Student’s t-test; (C): ANOVA; Bonferroni’s multiple comparison test, p< 0.05, p< 0.01.
A. QRT-PCR analysis of MACS-enriched Sca1pos cells from adult hearts confirming unchanged b-catenin expression but upregulation of its target genes and
endothelial markers in Klf15 KO versus WT. cDNA from total adult heart and –RT were used as controls.
B. FACS analysis of a mouse model with adult cardiac depleted b-catenin (b-catDex2–6) showed significantly reduced endothelial progenitor lineage (CD31pos),
in contrast to the upregulation observed in KLF15 KO mice.
C. Semi-quantitative immunohistochemistry analysis, confirming the observations in B.
D. Representative pictures of the CD31 immunoperoxidase staining of adult cardiac tissue of control, Klf15 KO, and b-catDex2-6 mice shown in C. Scale bar: 20mm.
1000Fig 7A). Along with this finding, mRNA expression of Flk1 and
CD31 was increased, whereas expression of Hand1 was
decreased following 10 days culture in Klf15 KO versus WT
CPCs (p< 0.05; Fig 7B). An increased endothelial-like cell
formation expressing CD31 was observed in Klf15 KO cells in
comparison to WT (Fig 7C).
To verify that the preferentially endothelial fate of Klf15 KO
CPCs is mediated by activation of b-catenin transcription, we
performed a co-culture rescue experiment where CPCs were
treated with 5mmol/L Quercetin, a known b-catenin transcrip-
tional inhibitor (Park et al, 2005). Quercetin was able to reverse
the b-catenin transcriptional activation in vitro as demonstrated
by luciferase gene reporter assay in HEK293 cells and
attenuation of b-catenin target gene activation in co-cultured
CPCs (Supporting Information Fig S7A and B). FACS
analysis after 10 days co-culture showed that the significant
increase of Flk1 in Klf15 KO CPCs was partially reversed upon
Quercetin treatment in comparison to the DMSO-treated Klf15
KO CPCs. Moreover, the increase in cells expressing Ki67 as well
as the reduction of aMHCpos and Hand1pos CPCs observed 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.in Klf15 KO CPCs was completely abrogated (Fig 7A and D).
The significantly increased cell number in Klf15 KO CPCs as
well as the significantly decreased proliferation in Quercetin
treated Klf15 KO CPCs was confirmed via semi-quantification
analysis following of 10 days culture (Fig 7D). Quercetin
treatment did not affect WT CPC cell number.
Collectively, these data show that regulation of b-catenin
transcriptional activity mediates regulation of cardiovascular
cell fate downstream KLF15 in the postnatal heart.DISCUSSION
To the best of our knowledge, we provide the first evidence
that KLF15 specifically interacts with components of the
Wnt/b-catenin pathway and inhibits b-catenin/TCF-dependent
transcriptional activation in cardiac cells. Moreover, our
findings show that KLF15 controls CPCs via regulation of
b-catenin transcription, which contributes to normal cardiac
homeostasis.EMBO Mol Med (2012) 4, 992–1007
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3
1002Cardiac interaction and regulation of the Wnt/b-catenin
pathway by KLF15
In this study, we found KLF15 to specifically interact with b-
catenin and TCF4 and to inhibit b-catenin/TCF-dependent
transcription in cardiac cells. In line with the fact that the KLF
proteins recruit co-factors to regulate transcription (Kaczynski
et al, 2003) we found KLF15 to interact with NLK, an inhibitor of
the b-catenin-LEF/TCF complex. We showed that a minimal
KLF15 N-terminal domain is essential for both protein
interaction and inhibition, which is consistent with the structure
of KLF proteins containing a transcriptional activation or
repression domain at the N-terminal region (Kaczynski et al,
2003). We showed that the first 45 amino acids are essential for
KLF15-b-catenin interaction. Moreover, the binding domain for
NLK as well as the repression domain is located between amino
acids 45 and 152 of the KLF15 N-terminus indicating an
important role of this interaction for transcriptional repression.
Thus, different KLF15 N-terminal domains are required for
binding both b-catenin and NLK suggesting that two different
interaction domains are present at the N-terminus probably
allowing for simultaneous binding to both b-catenin and NLK.
We also demonstrated that KLF15 C-terminus is essential for
binding TCF4 and for transcriptional repression, which may be
explained by the requirement of the C-terminal domain for
nuclear localization. This is in line with the identification of a
putative nuclear localization signal for KLF15 at amino acid 369
(Gray et al, 2002). Mechanistically, we found that KLF15 targets
TCF4 to ubiquitination, which was previously shown for NLK
(Ishitani et al, 2003). Our data suggest that KLF15 may recruit
NLK to the b-catenin/TCF-complex to prevent transcriptional
activation by targeting TCF4 for proteasomal degradation.
We demonstrate that several N-terminal mutants of KLF15
were able to translocate into the nucleus but were insufficient to
inhibit b-catenin/TCF4 transcription. These data show that
KLF15 requires both the C-terminus for nuclear translocation
and a minimal N-terminal regulatory region to exert inhibition
on b-catenin/TCF transcriptional activation. Similarly, another
KLF member, KLF4, was shown to inhibit b-catenin function by
preventing b-catenin binding to transcriptional mediators
(Zhang et al, 2006). These findings suggest specific members
of the KLF family proteins to allow tissue-specific inhibition of
the globally expressed Wnt/b-catenin pathway and render
KLF15 as an important cardiac regulator of b-catenin/TCF
transcription.Figure 7. CPCs of Klf15 KO acquire an endothelial phenotype via activation o
tailed Student’s t-test; (A) and (D) ANOVA; Bonferroni’s multiple comparison test, 
C and D 50mm.
A. Klf15 KO versus WT cells showed an augmented cell population in the scatte
decreased cardiac aMHCpos and Hand1pos populations in Klf15 KO cultured C
Quercetin (n¼ 6). Representative immunofluorescence pictures of co-cultures
B. QRT-PCR analysis of CPCs 10 days in co-culture confirming the significant upre
CD31 was found increased in Klf15 KO versus WT cultured CPCs.
C. Endothelial tube-like networks observed in 15-day Klf15 KO cultured CPCs; re
Sca1/aMHC.
D. Semi-quantitative analysis and representative pictures resulted in an increased
treatment.
 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.KLF15 regulates cardiac b-catenin transcription and is
important for cardiac homeostasis
Our in vitro finding showing KLF15-dependent b-catenin/TCF
transcriptional regulation prompted us to investigate this
regulation in vivo using a Klf15 KO mouse. Deletion of KLF15
resulted in an initial mild cardiac functional deterioration,
which was aggravated with aging. Cardiac activation of
b-catenin/TCF-dependent transcription was observed in Klf15
KO mouse. It is consistent with our in vitro results showing
inhibition of b-catenin transcription by KLF15, indicating that
no compensation for KLF15 concerning Wnt transcriptional
regulation takes place in the heart. Previous studies demon-
strated a role of KLF15 in regulating hypertrophic signalling and
fibrosis of the adult heart (Fisch et al, 2007; Haldar et al, 2010;
Leenders et al, 2010; Wang et al, 2008). Similar to these
functional observations, we confirmed exacerbated reduced LV
function in response to TAC along with cardiac hypertrophy and
fibrosis as well as accentuated LV dilation after AngII infusion in
Klf15 KO mice. However, at baseline we did not find neither
activation of hypertrophic pathways, nor increased fibrosis in
Klf15 KO mice. Our data show that the previously identified
KLF15-dependent mechanisms regulating hypertrophy and
fibrosis upon induced cardiac hypertrophy are not activated
in absence of any stimuli, suggesting an alternative mechanism
through which KLF15 controls normal cardiac homeostasis.
KLF15 regulates CPC fate in the postnatal heart
We previously described increased cardiomyogenic differentia-
tion of the sub-population of Sca1pos cells upon b-catenin
depletion in the postnatal heart (Zelarayan et al, 2008). In this
study, we demonstrated expression of KLF15 not only in total
CPCs but also specifically in the Sca1pos sub-population.
Therefore, we reasoned that KLF15-dependent regulation of
b-catenin transcription affects CPC biology. CPCs from Klf15 KO
were augmented in the proliferative cell cycle phase G2 and
specifically the Sca1pos and c-kitpos CPC sub-populations
showed increased proliferation in Klf15 KO versus WT. This
might be explained by an enhanced b-catenin transcriptional
activation as described in several studies showing that Wnt/b-
catenin signalling is required for proliferation and expansion
of specified cardiovascular progenitors during development
(Gessert & Kuhl, 2010). Due to the lack of specific markers for
different CPC populations, we combined stem cell markers with
markers of early and mature lineages to identify stem cells inf b-catenin-dependent transcription. Data represent mean SEM; (B) two-
p< 0.05, p<0.01, p< 0.001; ns: non-significant; scale bar in A 20mm; in
r plots gate G1. FACS analyses show increased Flk1pos and Ki67pos cells and
PCs. This was reversed by blocking b-catenin transcription with 5mmol/L
are shown.
gulation of Flk1 as well as downregulation of Hand1 expression. Expression of
presentative immunofluorescence pictures showing expression of CD31 and
cell number in Klf15 KO versusWT mice, which was reversed upon Quercetin
EMBO Mol Med (2012) 4, 992–1007
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mesodermal/endothelial cells (Flk1, CD31). Klf15 KO mice
showed a significant reduction of the cardiomyogenic progeni-
tors in contrast to an increase of endothelial progenitors in the
Sca1pos CPC pool in vivo and in vitro. Moreover, an early
upregulation of cells expressing the mesodermal/haemangio-
blastic marker Flk1 followed by an increase in CD31 expression
was detected in vitro. These finding suggest an endothelial
preference of Klf15 KO CPCs further supported by an increased
expression of a combination of endothelial markers including
vWF and CD105, the latter commonly used to trace endothelial
differentiation. In parallel we observed a reduction of CD133,
which is expressed in undifferentiated progenitors of the
endothelial lineages and becomes lower during its differentia-
tion (Shmelkov et al, 2005).
Further substantiating these data, the isolated Sca1pos sub-
population showed upregulation of endothelial markers in Klf15
KO mice suggesting an activation of an endothelial differentia-
tion gene program. Recently, the Sca1pos/CD31pos cardiac side
population cells were described as progenitors of cardiac
endothelial cells (Liang et al, 2011). Similar to our observations,
they showed vascular tube-like network formation along with
upregulation of CD133 in undifferentiated state and upregula-
tion of vWF during differentiation.
Our analysis showed an increase in the c-kitpos CPC as well as
the c-kitpos endothelial fraction upon KLF15 deletion, although
the number of cells was very low and no changes in the
cardiomyogenic pool were observed. These observations might
be explained by the fact that the adult c-kit population was
shown not to play a role in generating cardiomyogenic cells in
the adult heart (Zaruba et al, 2010).
Imbalance of the cardiomyogenic and endothelial CPCs in Klf15
KO mice was also observed upon mild and stringent induced
stress, which indicates that KLF15-dependent control of CPCs
plays also a role during stress induced remodelling. In conclusion,
KLF15 loss-of-function favours the expansion and commitment of
CPCs to endothelial cells thus regulating the compartment of CPCs
in the postnatal heart, which has critical implications in the
control of cardiac homeostasis. Similarly, pathways involved in
early CPCs specification were shown to control homeostasis of
the normal and injured heart (Boni et al, 2008).
KLF15 regulates CPC fate via regulation of b-catenin
transcription
Our study clearly shows a b-catenin/TCF activated transcription
upon KLF15 deletion in vivo, which results in a preferentially
endothelial CPC phenotype. In contrast, we previously showed
that cardiac b-catenin deletion promoted CPC differentiation
towards cardiomyogenic cells (Zelarayan et al, 2008). Here, we
further showed that mice with cardiac b-catenin depletion
exhibit the opposite phenotype as observed in Klf15 KO, namely
a reduction of endothelial-like CPCs in vivo. As expected, CPCs
from mice with a cardiac stabilization of b-catenin showed a
decreased cardiomyogenic CPC differentiation in vitro (Zelara-
yan et al, 2008) similarly to Klf15 KO CPCs. These findings
strongly indicate that KLF15 controls CPCs homeostasis in the
adult heart via regulating b-catenin/TCF transcription.EMBO Mol Med (2012) 4, 992–1007To further test the hypothesis that b-catenin transcriptional
activation mediates CPC regulation downstream KLF15, we
blocked b-catenin transcription in CPCs using a pharmacolo-
gical approach via Quercetin. Confirming our hypothesis, this
treatment reversed the increase in CPC proliferation, Flk1 cells
and endothelial markers. Moreover, the reduction of cardio-
myogenic cells was observed specifically in Quercetin treated-
Klf15 KO versus DMSO-Klf15 KO. Quercetin treatment of WT
CPCs did not affect endothelial or cardiomyogenic CPCs, while
the slight reduction observed in proliferation can be explained
by the fact thatWnt/b-catenin transcription is also attenuated in
the WT CPCs. Together these data indicate that b-catenin
transcription downstreamKLF15 is critical for CPC homeostasis.
This is supported by the fact that similar to the cardiac
phenotype observed in Klf15 KO, mice with a long term
induction of cardiac b-catenin stabilization exhibited reduced
LV function. Other studies showed that stimulation of b-catenin
transcription leads to cardiac impairment and accelerated
myocardial remodelling (Malekar et al, 2010).
It is important to mention that during early development, two
mesodermal Flk1pos cell populations are defined. An early
mesodermal haemangioblastic cell population expressing Flk1
but not the multi-potent cardiac marker Mesp1 develops into
endothelial cells and the blood lineage. A later mesodermal Flk1
population co-expressing Mesp1 results in a progenitor pool for
the all the cardiovascular lineage (Gessert & Kuhl, 2010;
Kouskoff et al, 2005). Expression of Flk1 is sequentially lost in
the cardiomyogenic population while it expression persists in
the endothelial lineages. Active Wnt/b-catenin signalling
activates these mesodermal progenitors to become haemangio-
blasts and inactivation of Wnt/b-catenin through Notch will
allow them to become cardiomyogenic cells (Chen et al, 2008;
Gessert & Kuhl, 2010; Naito et al, 2006; Ueno, 2007). Similarly,
our in vivo and in vitro data showed that KLF15 deletion leads
to an early upregulation of mesodermal haemangioblastic cell
marker Flk1, which leads to a final upregulation in the
endothelial CD31 population by regulating activation of
the Wnt/b-catenin signalling. Likewise, b-catenin maintains
normal homeostasis of progenitor pools in the gut (Pinto &
Clevers, 2005) and nervous system (Zechner et al, 2003).
We conclude that b-catenin transcriptional activation in
the absence of KLF15 favours an increased endothelial cell
while repressing cardiac myogenic differentiation. KLF15 is
essential to maintain the balance of early differentiating CPCs,
which may have critical implications in the control of heart
homeostasis and its adaptation to pathologic states (Fig 8).
These observations allow us to conclude that an altered CPC
homeostasis might be another cellular mechanism aside cardiac
hypertrophy that contributes to enhanced cardiac deterioration
upon deletion of KLF15. Both scenarios are not mutually
exclusive, and may contribute to heart failure development.
Importantly, KLF15 is expressed in human adult cardiac tissue
and similar to the finding in mouse, is known to be
downregulated in the failing heart (Fisch et al, 2007; Haldar
et al, 2010). Our study reveals an interesting regulation that
could be exploited to activate human CPCs upon cardiac
remodelling. 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1003
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Figure 8. Hypothetical in vivo role of KLF15 and Wnt/b-catenin crosstalk
in the adult heart. Interactions among KLF15, NLK and the nuclear b-catenin/
TCF-complex repress canonical Wnt signalling to maintain a balance of
cardiovascular committed progenitor cell pool and a normal cardiac
homeostasis. Loss of KLF15 leads to an upregulation of b-catenin/TCF-
dependent transcription and displaces cardiovascular progenitors to acquire
an endothelial rather than a cardiac identity.
1004In summary, our present study shows a novel and important
level of regulation of endogenous CPC specification, which may
play a significant role in the regeneration of the injured heart.
Our data provide an insight into the molecular mechanisms
driving CPC biology by demonstrating the potential of KLF15 to
modulate CPC cell fate via regulation of the Wnt/b-catenin
signalling. It makes this pathway a suitable target for therapeutic
approaches to treat pathological cardiovascular adaptation.MATERIALS AND METHODS
Mouse strains
The KLF15 loss-of-function mouse (Klf15 KO) was achieved by an out-
of-frame insertion of a lacZ cassette in exon 2 of the KLF15 coding
region. The Klf15 KO mouse was kindly provided by Dr. HJ Schaeffer/
Prof. W Birchmeier. Inducible, cardiac specific b-catenin gain-of-
function (aMHC-CrePR1/b-CatDex3) was achieved by flanking exon 3
with loxP sites of the b-catenin coding region. Heart-specific
expression of the Cre recombinase under control of the aMHC
promoter was activated by administration of the estrogen derivate
mifepristone (RU486, 30mg/kg body weight/day; Sigma–Aldrich)
i.p. for 5 days. Excision of exon 3 results in a non-degradable mutant
of b-catenin (Baurand et al, 2007).
Inducible, cardiac specific b-catenin loss-of-function (aMHC-MerCre-
Mer/b-catDex2–6) was achieved by flanking exon 2–6 with loxP sites of
the b-catenin gene. Heart-specific expression of the Cre recombinase
under control of the aMHC promoter was activated by administration
of 90ml Tamoxifen (10mg/ml; Sigma–Aldrich) i.p. for 4 days.
Littermates negative for Cre recombinase were used as control. The
experiments were approved by the Niedersachsen (AZ: 10/0230)
animal review board.
Cell culture
HEK293 cells were grown in DMEM and SW480 in RPMI both
supplemented with 10% FCS/L-glutamine/antibiotics. NRC were
isolated and cultured as described previously (El Jamali et al, 2004). 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.For isolation of cardiac fibroblast, adult mice were anesthetized
and hearts were dissected, minced and digested with collagenaseII/
trypsin and cultivated in DMEM/F12 supplemented with 10%
FCS/L-glutamine/antibiotics/100mM ascorbic acid. For isolation of a
non-cardiomyocyte cell fraction, adult mice were anesthetized and
hearts were dissected, minced and filtered through 40 and 30mm
mesh. Cells were used directly for FACS staining or seeded on
MitomycinC (Sigma–Aldrich)-arrested adult cardiac fibroblasts and
cultivated for 10 days at 378C, 5% CO2 in DMEM/F12 supplemented
with 2% FCS/L-glutamine/antibiotics/100mM ascorbic acid. For rescue
experiments co-cultures were treated with 5mmol/L Quercetin
hydrate (Acros Organics) for 10 days; control cells were treated with
the solvent DMSO.
Co-immunoprecipitation and ubiquitination assays
HEK293 cells and NRC were transfected with expression plasmids for
cmyc-b-catenin, HA-TCF4, HA-NLK, Flag-KLF15 (full length, -DN45,
-DN152, -DN260, -DC) and pcDNA3.1. Cells were harvested 48h after
transfection, lysed with radio-immunoprecipitation assay (RIPA) buffer
with protease inhibitors, and immunoprecipitated with antibodies
against cmyc-(Santa Cruz), HA-, or Flag-tag (Sigma–Aldrich). Interact-
ing proteins were detected by immunoblotting using the appropriate
anti-tag-HRP antibodies (1:2000; Sigma–Aldrich). As controls, protein
lysates transfected with EV and precipitation with IgG isotype control
were used. Whole cell lysates were immunoblotted with respective
antibodies to detected protein expression. Endogenous co-immuno-
precipitation was performed with an antibody against KLF15 (Santa
Cruz). Interacting proteins were detected by immunoblotting using
the appropriate anti-b-catenin, -NLK and -TCF4 antibodies (1:1000).
IgG isotype control was used as a co-immunoprecipitation control.
For ubiquitination assay RIPA buffer was supplemented with 10mmol/
L N-ethylmaleimide (NEM; Sigma–Aldrich). TCF4 was immunoprecipi-
tated with anti-HA antibody (Sigma–Aldrich). Ubiquitination of TCF4
was analyzed by immunoblotting using anti-ubiquitin antibody
(1:1000; Cell Signaling) and anti-rabbit-HRP secondary antibody
(1:10,000; Dako).
Luciferase reporter assay
HEK293, SW480 cells, and NRC were co-transfected with plasmids
expressing non-degradable b-catenin (b-cat-DN) or TCF4 and various
amounts of full-length and truncated constructs of KLF15 (250pg–
250ng) along with the pTOPflash luciferase reporter (750 ng) and
Renilla luciferase expressing plasmid (5 ng) as a normalizing control.
pFOPflash containing mutated TCF binding sites was used as negative
reporter control. Luciferase activity was determined using Dual-
Luciferase Reporter Assay (Promega) 48 h after transfection, according
to manufacturer’s instructions.
Flow cytometry analysis
The non-cardiomyocyte population was prepared as mentioned above.
Cells were fixed in 1% formaldehyde/PBS, permeabilized in FACS buffer
containing 0.5% Saponin (Sigma–Aldrich) and stained with anti-
CD31-FITC, -Flk1-PE, -Sca1-FITC, c-kit-APC (1:200; eBioscience) anti-
aMHC, -Tbx5, -cTnT (1:500; Abcam); -Ki67-PE, and -Hand1 (1:200;
Santa Cruz). The cells were subsequently stained with anti-rabbit IgG-
APC or anti-mouse F(ab)2-FITC (1:500; Jackson ImmunoResearch).
Respective isotype controls were used. For cell cycle analysis theEMBO Mol Med (2012) 4, 992–1007
www.embomolmed.org Research Article
Claudia Noack et al.
The paper explained
PROBLEM:
Heart failure is characterized by an imbalanced myocardial
damage and repair. Unfortunately, the therapeutic modalities to
prevent heart failure are currently limited. It is now well
accepted that regeneration events occur in the adult mammalian
hearts during normal aging and disease. Although low levels of
cardiomyocyte renewal are detectable in the adult heart,
promising pharmaceutical or genetic therapy approaches could
be developed to enhance this effect. Therefore, the elucidation of
cardiac progenitor cell contribution to cardiac homeostasis,
aging and injury along with the molecular signalling directing
these events is essential to help to promote postnatal cardiac
regeneration. Thus, we need to focus our efforts to explore these
processes to benefit from endogenous mechanisms and to be
able to exploit them therapeutically. Wnt/b-catenin pathway is
essential for embryonic cardiogenesis and for normal cardiac
homeostasis and remodelling. Therefore, this pathway is a good
candidate to be investigated in endogenous CPC biology.
RESULTS:
The present study provides a detailed biochemical and functional
analysis of a novel interaction between a member of the KLF
family (KLF15) and Wnt-pathway components, which leads to
repression of the Wnt transcriptional activity. We clearly show
the presence of two important domains within the KLF15 protein
sequence, a minimal N-terminal region and the C-terminus,
which are essential for b-catenin/TCF4 transcriptional repression
in cardiac cells. Moreover, using a genetic model we report the
role of KLF15 in the regulation of the CPC biology in the postnatal
heart in vivo and in vitro. Klf15 knockout mice exhibit a de-
repression of b-catenin/TCF4 transcription. This shifts the cell
fate of cardiovascular progenitors towards an endothelial lineage
antagonizing cardiogenic cell formation in the healthy and
stressed heart, similar to what has been observed in embryonic
development. Moreover, the endothelial cell fate shift can be
reversed upon inhibition of the Wnt activation in vitro, which
demonstrated that KLF15 controls CPCs cell fate via regulation of
b-catenin transcription.
IMPACT:
This work may have identified a novel molecular switch to
therapeutically modulate CPC fate and unlock the regenerative
potential of the adult heart. It might help to prevent massive
cardiac loss upon injury. Specifically, our observations highlight the
role of KLF15 in controlling the early specification of the progenitor
pool to specifically generate different cardiovascular cellular
subtypes in the postnatal heart. This observation is of relevance
given the fact that KLF15 is expressed in the human heart and is
known to be dysregulated upon prohypertrophic stimuli. The
present data help us to understand the biological processes
leading to formation of cardiovascular cells from resident
precursors, which may have critical implications in the control of
heart homeostasis and its adaptation to pathologic states.isolated cells were fixed in cold 70% ethanol, treated with 100mg/ml
RNase and incubated with 50mg/ml propidium iodide. Fluorescence
signals were detected with a FACS-Calibur flow cytometer (Becton
Dickinson).
Magnetic activated cell sorting
The non-cardiomyocyte population was prepared by mincing
and 1mg/ml collagenase II digestion, stained with anti-Sca1-FITC
(1:10; Miltenyi Biotec) and labelled with anti-FITC-MicroBeads
(1:5; Miltenyi Biotec). Sca1pos cells were enriched by two rounds of
MS Columns (Miltenyi Biotec) separation. Purity was checked by FACS
analysis. Sca1pos cells were directly applied to mRNA extraction.
RNA isolation, reverse transcription and quantitative
real-time PCR analysis
Total RNA was isolated from cardiac mouse tissue using the
NucleoSpin RNA II kit (Macherey-Nagel), according to manufacturer’s
instruction and treated with DNase. cDNA was synthesized with
Oligo(dT)20 primer and M-MLV reverse transcriptase (Promega).
Quantitative real-time PCR analyses were performed with SYBR
Green (Qiagen) on an iCycler instrument (BioRad). Copy numbers
were calculated using the iCycler software with a relative standard
curve obtained using the log dilutions of cDNA of gene of interest. All
reactions were run in triplicates and normalized to both referenceEMBO Mol Med (2012) 4, 992–1007control genes Gapdh and b-actin applying the geometric mean
calculation. Primers are listed in Supporting Information Table S3.
Immunocytochemistry
HEK293 and NRC were grown on poly-L-lysin or 1% gelatine coated
coverslips, respectively; fixed in 4% PFA, permeabilized in 0.1%
TritonX-100 and blocked in 1% BSA for 1 h at RT. Cells were incubated
with respective antibodies against b-catenin (BD Bioscience), NLK
(Bethyl Laboratories), KLF15 (Abcam), HA-tag (Sigma–Aldrich) and
Flag-tag (Sigma–Aldrich) at 1:200 dilutions O/N at 48C.
Cardiac progenitor cells were grown on fibroblast on gelatine-coated
coverslips. Cells were blocked in 2% FCS; surface markers were
detected with anti-Flk1 (1:200; eBioscience), anti-CD31-FITC
(1:200; eBioscience) for 1 h at 48C. Next, cells were fixed in 1% PFA,
permeabilized in 0.3% TritonX-100/0.2% BSA and blocked in
0.1% TritonX-100/5% BSA for 1 h at RT. Intracellular staining
was performed with antibodies against Hand1 (1:100; Santa Cruz)
and O/N at 48C.
AlexaFluor488 and AlexaFluor594 conjugated secondary antibodies
(1:200; Invitrogen) were used for immunofluorescence labelling. For
nuclei visualization cells were incubated with Hoechst33342 (Sigma–
Aldrich) for 5min and mounted with ProlongGold (Invitrogen).
Microscopic images were captured with a confocal microscope (710,
Zeiss). 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1005
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1006Histological analysis
Heart, liver, lung and kidney were rinsed in PBS, fixed in 4% PFA,
embedded in paraffin and sectioned at 3mm. Sections were de-
paraffinized and used for the different stainings. Liver, lung and kidney
were stained with Weigert’s haematoxylin/Eosin. For visualization of
cardiac fibrosis sections were stained with Weigert’s iron haematox-
ylin staining and Accustain-Trichrome according to manufacturer’s
instructions for Masson-Trichrome staining (Sigma–Aldrich), and with
DirectRed80 1 h (Sigma–Aldrich) for Sirius Red staining. Detection of
apoptosis was performed with indirect TUNEL ApopTag Red in situ
Apoptosis Detection Kit (Chemicon) according to manufacturer’s
instruction. To assess the cross-sectional area (CSA) of cardiomyocytes
sections were stained with 20mg/ml lectin wheat germ agglutinin
(WGA) FITC (Sigma–Aldrich) and mounted with ProlongGold (Invitro-
gen), random fields were photographed and 150 cells were counted to
calculate CSA using semiautomatic AxioVision software (Zeiss).
Microscopic images were captured with a digital microscope (IX70,
Olympus).
Immunohistochemistry was performed in de-paraffinized heart
sections. Slides were microwaved for antigen retrieval in citrate buffer
and endogenous peroxides were blocked. Slides were incubated with
a rabbit anti-CD31 (1:50; Abcam) O/N, then washed in PBS and
incubated with a secondary goat anti-rabbit IgG (1:200; Sigma–
Aldrich) 1 h at 378C. After additional washing in PBS preparations
were incubated 1 h at 378C in a rabbit peroxidase-antiperoxidase
complex (Sigma–Aldrich), subsequently washed and bound peroxidase
was revealed by incubation with 3,30-diaminobenzidine tetrahy-
drochloride (DAB, 0.05% in PBS). Microscopic images were captured
with a digital microscope (M2, Zeiss) and the staining was semi-
quantified using ImageJ software.
Echocardiographic analysis
Mice were anesthetized by 2.4% isoflurane inhalation and ventricular
measurements were done with a VisualSonics Vevo 2100 Imaging
System equipped with a 45MHz MS-550D MicroScan transducer. The
observer was unaware of the genotypes and treatments.
Statistical analysis
Differences between experimental groups were analyzed using two-
tailed Student’s t-test or ANOVA test followed by Bonferroni’s multiple
comparison test. Data are presented as mean SEM. p<0.05 values
were considered significant.Author contributions
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